Skip to main content
Premium Trial:

Request an Annual Quote

OpGen Increases Public Offering to Up to $15.6M

NEW YORK (GenomeWeb) – OpGen today raised the amount it plans to publicly offer in stocks and warrants to up to $15.6 million,

The firm previously said it planned to offer up to $10 million in stocks and warrants.

OpGen said in an amended prospectus filed with the US Securities and Exchange Commission that it has not priced the offering but said that it will offer 13.7 million shares of its common stock and warrants to purchase an aggregate of more than 6.8 million shares of its common stock. Net proceeds from the offering are estimated at $8.5 million, based on an assumed offering price of $.73 per share of common stock. If the warrants are exercised in full at an exercise price of $.73 per share, net proceeds will increase by $5 million, the firm said.

Last week, OpGen said that it was warned by Nasdaq that it faced possible delisting action because its shares fell below a minimum bid price of $1 per share.The company was also warned in May that it is non-compliant with a listing requirement calling for a minimum of $2.5 million in stockholders' equity.

In afternoon trading on Thursday, shares of OpGen on the Nasdaq were down 3 percent to $.72 per share.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.